The session covers types and biological activities of antibody classes.
Two major lymphocyte populations in adaptive immunity:
B lymphocytes (B cells)
T lymphocytes (T cells)
B lymphocytes mature in bone marrow and express a unique antigen-binding receptor known as the antibody (B-cell receptor).
Antigen binding to the antibody causes B cells to divide rapidly.
Daughter B cells differentiate into:
Memory B cells
Effector B cells/plasma cells
Effector B cells/plasma cells secrete a large number of antibodies into circulation, serving as major effector molecules of humoral immunity (B-cell mediated immunity).
Antigens are generally complex structures not entirely recognized by B cells or antibodies.
Antibodies recognize specific regions on an antigen called antigenic determinants or epitopes.
Epitopes are the active regions on the antigen that bind to the antibody receptor.
Antibodies recognize various epitopes on bacteria, viruses, proteins, glycoproteins, polysaccharides, or lipopolysaccharides on invading pathogens.
The part of the antibody that recognizes and binds to the epitope is known as a paratope.
Antigens (foreign proteins, viruses, bacteria, parasites, fungi) interact with B cells.
B cells differentiate into antibody-secreting plasma cells.
Antibodies bind to antigens and facilitate their clearance from the body.
The antibody molecule consists of light chains and heavy chains.
It includes a hinge region and antigen-binding sites.
The variable portion is responsible for antigen recognition, while the constant portion determines functional properties.
The light chains can be either kappa (κ) or lambda (λ).
The heavy chain determines the isotype (IgG, IgA, IgM, IgD, IgE).
Fab region: Fragment antigen-binding region.
Fc region: Fragment crystallizable region. Determines functional properties of the antibody.
Heavy chain: Contains one variable VH domain, followed by a constant domain CH1, a hinge region, and two more constant domains CH2 and CH3.
Light chain: Contains one variable VL and one constant CL domain. Can be either kappa (κ) or lambda (λ).
Light chains in the constant region are of two types: kappa (κ) and lambda (λ).
A single antibody contains either kappa or lambda light chains, but not both.
If a B lymphocyte generates an antibody with a kappa light chain, it will bear this kappa light chain throughout its lifetime.
Regions of constant sequence are called C regions: CL on the light chain and CH on the heavy chain.
The C-terminal fragment is called the Fc region, which determines the functional properties of the antibody.
Antibodies bind to antigens and stimulate immune responses for antigen removal and pathogen death.
Antibodies do not kill pathogens simply by binding to them; they must stimulate immune responses.
Effector functions play a major role in humoral or antibody-mediated response.
The variable Fab region is responsible for binding to the antigen.
Antigen binding alone cannot initiate an immune response.
Antibodies facilitate binding of immune cells/proteins or tissues through the Fc region (constant region of the heavy chain).
Effective immune response requires both:
Binding of antigen to the Fab region
Interaction of immune cells/proteins to the Fc region.
The Fc region of the antibody molecule defines the five antibody classes:
Immunoglobulin G (IgG)
Immunoglobulin M (IgM)
Immunoglobulin A (IgA)
Immunoglobulin D (IgD)
Immunoglobulin E (IgE)
Fc region or antibody classes bind to different serum proteins or cell-membrane receptors based on the immune response needed.
Each antibody class (IgM, IgG, IgA, IgD, IgE) has different functional properties, distributions, and functions in the body.
Class | Percentage of Total | Characteristics and Functions |
---|---|---|
IgG | 75% | Found in blood, lymph, and intestines. Active against bacteria, toxins, and viruses. Enhances phagocytosis, crosses the placenta, and is active in a secondary response. |
IgA | 10-15% | Saliva, tears, bronchial, GI, prostatic, and vaginal secretions. Provides local protection on exposed mucous membrane surfaces and potent antiviral activity. Prevents absorption of antigens from food and protects against respiratory, GI, and GU infections. Levels decrease during stress. |
IgM | 5-10% | Found in blood and lymph. The first antibody produced in the primary immune response. High concentrations early in infection, decreasing within about a week. |
IgD | <1% | Unknown function, found in blood and lymph. |
IgE | <0.1% | Found on mast cells and basophils. Involved in immediate hypersensitivity response. |
Most abundant antibody class in serum (about 80% of total serum immunoglobulins).
Subdivided into four subclasses based on differences in amino acid γ-chain sequence:
IgG1
IgG2
IgG3
IgG4
Distinguished by:
Size of the hinge region
Number and position of interchain disulfide bonds between heavy chains.
Subclasses are more than 90% identical but differ in antigen binding, immune complex formation, complement activation, triggering of effector cells, half-life, and placental transport.
Main biological activities:
Activation of compliment pathway
Binding to Fc receptors of phagocytes
Crossing the placenta to protect the developing fetus from infectious agents.
IgG1, IgG3, and IgG4 readily cross the placenta and bind to Fc receptors on phagocytic cells to mediate opsonization.
IgG1 and IgG3 are involved in the complement activation pathway.
IgG2: Antibody response against encapsulated bacteria (e.g., Streptococcus pneumoniae).
IgG4: Allergens are inducers; antibodies are often formed following repeated or long-term exposure to antigens in a non-infectious setting.
Property | IgG1 | IgG2 | IgG3 | IgG4 |
---|---|---|---|---|
Ability to activate classical complement pathway | Moderate | Minimal | High | No |
Ability to bind to Fc receptors on Phagocytes | High | Minimal | High | Moderate |
Ability to cross Placenta to protect fetus | Moderate | Minimal | Moderate | Moderate |
Normal serum level (mg/ml) | 9 | 3 | 1 | 0.5 |
Accounts for 5%–10% of total serum immunoglobulin, with an average serum concentration of 1.5 mg/ml.
Secreted by plasma cells as a pentamer held together by disulfide bonds.
Each pentamer contains an additional Fc-linked polypeptide called the J (joining) chain, required for polymerization.
First immunoglobulin class produced in a primary response to an antigen and synthesized by newborn babies.
Pentameric structure with 10 antigen-binding sites gives it a higher valency (combining power).
More efficient at activating the classical complement pathway than IgG.
Due to its large size, IgM does not diffuse well.
Property | Value |
---|---|
Ability to activate Classical complement Activation Pathway | High |
Ability to bind to Fc receptors on Phagocytes | Unknown |
Ability to cross Placenta to protect fetus | No |
Mucosal Transport | Moderate |
Normal serum level (mg/ml) | 1.5 |
Increases phagocytosis.
Participates in agglutination and opsonization.
Features a significant number of antigenic sites, facilitating efficient immune activation.
Constitutes 10%–15% of the total immunoglobulin in serum.
Predominant immunoglobulin class in external secretions (milk, saliva, tears, mucus).
Exists primarily as a monomer in serum but also in polymeric forms (dimers, trimers, tetramers).
Polymeric forms of IgA contain a J chain, which facilitates polymerization.
Secreted by epithelial cells of mucous membranes.
Comprises a dimer or tetramer, a J-chain, and a secretory component.
The secretory component consists of five immunoglobulin-like domains that bind to the Fc region domains of the IgA dimer.
Protects IgA antibodies from proteolytic degradation.
Prevents attachment to the host epithelial surface.
Daily production of secretory IgA is greater than that of any other immunoglobulin class.
Serves as an important protective barrier at mucous membrane surfaces.
Active against Salmonella, Vibrio cholerae, Neisseria gonorrhoeae, and viruses such as polio, influenza, and reovirus.
Cross-links large antigens with multiple epitopes.
Prevents attachment of pathogens to mucosal cells, inhibiting viral infection and bacterial colonization.
Complexes of secretory IgA and antigen are entrapped in mucus and eliminated by ciliated epithelial cells or peristalsis.
Property | Value |
---|---|
Ability to activate Classical complement Activation Pathway | No |
Ability to bind to Fc receptors on Phagocytes | No |
Ability to cross Placenta to protect fetus | No |
Mucosal Transport | Moderate |
Normal serum level (mg/ml) | 0.5-3 |
Present in all secretions, including colostrum and milk.
Crucial for respiratory and gastrointestinal defense.
Essential for the passive acquisition of immunity by a nursing infant.
Enhances the effectiveness of lysozyme, particularly against gram-negative bacteria.
Neutralizes viruses.
Found in respiratory and gastrointestinal system linings and responds to allergic reactions.
IgE antibodies mediate immediate hypersensitivity/allergic reactions.
Exists in extremely low concentration in serum (0.0003mg/ml) but has potent biological activity.
Binds to Fc receptors on the membranes of blood basophils and tissue mast cells.
Cross-linkage of receptor-bound IgE molecules by antigen (allergen) induces basophils and mast cells to translocate their granules to the plasma membrane.
Granules are released into the extracellular environment (degranulation).
Releases pharmacologically active mediators (such as histamines) into the circulation, giving rise to allergic reactions.
Property | Value |
---|---|
Ability to activate Classical complement Activation Pathway | No |
Ability to bind to Fc receptors on Phagocytes | No |
Ability to cross Placenta to protect fetus | No |
Induces mast cell degranulation | Moderate |
Normal serum level (mg/ml) | 0.0003 |
Serum concentration of 0.03mg/ml, constitutes about 0.2% of total immunoglobulin in serum.
Functions as a receptor on the surface of mature B-cells.
Involved in their activation and differentiation.
Serves as a signal for B cells to start the differentiation process.
No biological effector function has been identified for IgD.
Acts as a B-cell receptor.
Property | Value |
---|---|
Ability to activate Classical complement Activation Pathway | No |
Ability to bind to Fc receptors on Phagocytes | No |
Ability to cross Placenta to protect fetus | No |
Present on the membrane of B cells | Minimal |
Normal serum level (mg/ml) | 0.03 |